Detalhe da pesquisa
1.
Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor.
Nat Chem Biol
; 13(11): 1164-1171, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28892090
2.
Identification of microRNA biomarker candidates in urine and plasma from rats with kidney or liver damage.
J Appl Toxicol
; 37(3): 278-286, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27397436
3.
The beagle dog MicroRNA tissue atlas: identifying translatable biomarkers of organ toxicity.
BMC Genomics
; 17: 649, 2016 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27535741
4.
The Rat microRNA body atlas; Evaluation of the microRNA content of rat organs through deep sequencing and characterization of pancreas enriched miRNAs as biomarkers of pancreatic toxicity in the rat and dog.
BMC Genomics
; 17: 694, 2016 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27576563
5.
Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy.
Blood
; 123(5): 632-9, 2014 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24335104
6.
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphoma.
Blood
; 116(9): 1515-23, 2010 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-20525923
7.
A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models.
Sci Transl Med
; 13(611): eaba7791, 2021 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34524860
8.
Identification of a lung cancer cell line deficient in atg7-dependent autophagy.
Autophagy
; : 0, 2015 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26090719
9.
KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism.
PLoS One
; 10(12): e0144825, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26709701
10.
Treatment-emergent mutations in NAEß confer resistance to the NEDD8-activating enzyme inhibitor MLN4924.
Cancer Cell
; 21(3): 388-401, 2012 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22439935
11.
Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib.
Blood
; 109(8): 3177-88, 2007 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17185464